Before You Buy,3262.5

Beta amyloid peptides are a group of highly studied molecules, primarily known for their association with Alzheimer's disease. Understanding their precise molecular weight is crucial for research into their formation, aggregation, and potential therapeutic interventions. This article delves into the specific molecular weights of various beta-amyloid peptides, exploring the factors that influence these values and their significance in scientific inquiry.

Amyloid beta peptides are generated through the proteolytic processing of the amyloid precursor protein (APP) by β-secretase and γ-secretase enzymes. The resulting peptides vary in length, with the most common forms being 40 and 42 amino acids long, often denoted as Aβ40 and Aβ42. These amyloid peptides are the primary constituents of the amyloid plaques found in the brains of individuals with Alzheimer's disease.

The molecular weight of these peptides is a fundamental characteristic that influences their physical and chemical properties, including solubility and aggregation behavior. While the amino acid sequence dictates the theoretical molecular weight, experimental determination and computational calculations can provide precise values.

For instance, the human beta-amyloid peptide (1-40) has a computed molecular weight of approximately 4330 g/mol. This value is derived from its specific amino acid composition.

In contrast, the slightly longer beta-amyloid peptide (1-42), also known as Aβ42, has a higher molecular weight. Various sources indicate values such as 4514 Da, 4514 g/mol, and 4513.05. Some sources provide a molecular weight of 4514.1 for the human form of Aβ42, further emphasizing the consistency of this value within a narrow range. The molecular formula for Aβ42 is often cited as C203H311N55O60S.

Beyond these predominant forms, other beta-amyloid peptide fragments also exist, each with its own distinct molecular weight. For example, beta-amyloid peptide (1-43) has a molecular weight of 4615.19 g/mol. Shorter fragments, such as β-amyloid (1-28), have a molecular weight of 3262.5. Even smaller fragments like β-amyloid (25-35) have a molecular weight of 1060.27. Another fragment, amyloid beta-protein (17-42), has a molecular weight of 2577.0 g/mol. The molecular weight of beta-amyloid (35-42) is reported as 744. Furthermore, amyloid beta (1-16) has a molecular weight (g/mol) of 1955.00. The molecular weight of β-amyloid (1-37) (human) is 4074.53.

It's important to note that the term "amyloid beta" can encompass a range of peptides with lengths typically between 36 and 43 amino acids. While Aβ40 and Aβ42 are the most studied, the ensemble of these peptides plays a role in neurological conditions. The structure of these peptides, particularly their tendency to misfold and aggregate into insoluble fibrils, is a central focus of Alzheimer's disease research.

In the context of scientific research, understanding the exact molecular weight is essential for accurate calculations, such as determining molar concentrations from mass. The relationship between mass, concentration, and molecular weight is fundamental: Mass = Concentration × Volume × Molecular Weight. This principle is applied when preparing solutions and conducting biochemical analyses.

The variations in reported molecular weight can sometimes be attributed to factors such as the presence of counterions (e.g., TFA, which is often associated with synthetic peptides) or slight differences in computational methodologies. However, the values for the most common beta amyloid peptides, particularly Aβ40 and Aβ42, are well-established within the scientific community, with values clustering around 4330 g/mol for Aβ40 and 4514 g/mol for Aβ42. The significant role these peptides play in disease pathogenesis underscores the importance of precise molecular characterization.